Researchers at Tampere University of Technology in Finland have developed the world's first biodegradable joint implant to treat osteoarthritis and rheumatoid arthritis, according to a News Medical report.
The new implant, RegJoint-, allows a patient's own bone tissue to remain intact during an operation, makes the reconstruction of the joint more sustainable, and provides a cushion that relieves pain caused by friction between bones.
Chronic Pain Can be Measured With Bar Code, Researchers Say
Low Dose of Naltexone Reduces Pain in Fibromyalia Patients, Study Finds
The new implant, RegJoint-, allows a patient's own bone tissue to remain intact during an operation, makes the reconstruction of the joint more sustainable, and provides a cushion that relieves pain caused by friction between bones.
Related Articles on Pain Management:
Long Term Opioid Use Can Lead to Hormonal Abnormalities, Study SaysChronic Pain Can be Measured With Bar Code, Researchers Say
Low Dose of Naltexone Reduces Pain in Fibromyalia Patients, Study Finds